Calgary Canada Class Action Xarelto Lawsuit Filed As A Second Canada Class Action Suit May Be Forming

BloodThinnerHelp.com comments on recent reports from a Calgary Sun article which note the formation of a class action lawsuit in Calgary, Canada which has been filed against Bayer Inc.,in relation to the new-generation blood thinner they manufacture, Xarelto. The lead plaintiff in this Canada class action lawsuit alleges that the anticoagulant drug caused her to suffer from an uncontrollable bleeding event which nearly led her to cardiac arrest.

This Canadian class action lawsuit closely follows the formation of Multidistrict Litigation number 2592 in the United States by the U.S. Judicial Panel on Multidistrict Litigation. This MDL consolidated and transferred over 2,800 lawsuits filed in reference to Xarelto by plaintiffs who allege much the same. These lawsuits are additionally joined by another group of 620 Xarelto lawsuits which have been formed into a mass tort program by the Court of Common Pleas in Philadelphia, Pennsylvania. Lawsuits in these groupings have been filed against defendant Bayer AG as well as Janssen Pharmaceuticals, a subdivision of Johnson & Johnson corporation.

According to reports published in the Calgary Sun, as of March 2015, Health Canada had received an estimated 1,100 adverse event reports from patients taking Xarelto. The article indicates that, according to a lawyer from Toronto, if the class action is successful, “...it would be in the millions of dollars.” The Calgary Sun report also discussed the likely formation of another class action suit in Ontario at this time.

In America, Xarelto gained approval from the U.S. Food and Drug Administration in 2011. The anticoagulant was approved to treat patients suffering from a pulmonary embolism, deep vein thrombosis, and atrial fibrillation, as well as those recovering from knee or hip replacement surgeries, who may be at heightened risk for the development of blood clots.

In just five year’s time, Xarelto has become the topic of increasing controversies and mounting lawsuits, which continue to grow in number today. The FDA has also given the blood thinner two “black box” warnings, which are the most strict warnings a product can receive before it is removed from the market for public sale.

In the thousands of lawsuits now surrounding the drug, plaintiffs commonly report experiencing side effects such as pulmonary embolisms (blood clots in the lung), epidural hematoma, rectal bleeding, stroke, heart attack, internal bleeding episodes, eye bleeds, gastrointestinal bleeding, and brain hemorrhages, some of which have proven fatal.

As thousands of Xarelto lawsuit plaintiffs await early 2017 bellwether trials, and other complaints continue to be filed, Attorney Joseph Osborne is working to help others who have used the blood thinner and who feel that it has negatively impacted their health. He wants to help ensure that affected patients will be provided with the important opportunity to investigate their legal rights in full. These individuals could be entitled to substantial compensation gained through legal action. To better help those wishing to explore their legal rights more, Attorney Osborne is currently offering free legal consultations to qualified parties.

To request more information, or to ask questions, please contact Attorney Joseph Osborne by calling (866) 425-8902.